Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease (Q38465993)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease
scientific article

    Statements

    Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease (English)
    Vladimir Coric
    Christopher H van Dyck
    Stephen Salloway
    Niels Andreasen
    Mark Brody
    Ralph W Richter
    Stephen Thein
    Thomas Shiovitz
    Gary Pilcher
    Susan Colby
    Linda Rollin
    Randy Dockens
    Chahin Pachai
    Ulf Andreasson
    Holly Soares
    Charles Albright
    Robert M Berman
    1 November 2012
    1430-1440

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit